XML 281 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   93,410,563        
Beginning balance at Dec. 31, 2021 $ 158,461 $ 9 $ 187,656 $ (8,983) $ 0 $ (20,221)
Beginning balance (in shares) at Dec. 31, 2021       (701,305)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (1,087,990)   (1,087,990)    
Repurchase of common stock (13,934)     $ (13,934)    
Stock-based compensation 1,605   1,605      
Exercise of stock-based awards, net of shares withheld (in shares)   161,969        
Exercise of stock-based awards, net of shares withheld 38   38      
Unrealized gain (loss) on interest rate caplets 4,864       4,864  
Net income 15,788         15,788
Ending balance (in shares) at Mar. 31, 2022   92,484,542        
Ending balance at Mar. 31, 2022 166,822 $ 9 189,299 $ (22,917) 4,864 (4,433)
Ending balance (in shares) at Mar. 31, 2022       (1,789,295)    
Beginning balance (in shares) at Dec. 31, 2021   93,410,563        
Beginning balance at Dec. 31, 2021 158,461 $ 9 187,656 $ (8,983) 0 (20,221)
Beginning balance (in shares) at Dec. 31, 2021       (701,305)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain (loss) on interest rate caplets 6,771          
Net income 38,252          
Ending balance (in shares) at Jun. 30, 2022   90,759,331        
Ending balance at Jun. 30, 2022 173,875 $ 9 191,190 $ (42,126) 6,771 18,031
Ending balance (in shares) at Jun. 30, 2022       (3,600,086)    
Beginning balance (in shares) at Mar. 31, 2022   92,484,542        
Beginning balance at Mar. 31, 2022 166,822 $ 9 189,299 $ (22,917) 4,864 (4,433)
Beginning balance (in shares) at Mar. 31, 2022       (1,789,295)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (2,326,413)   (2,326,413)    
Repurchase of common stock (25,498)     $ (25,498)    
Reissuance of treasury stock in business combination (in shares)   515,622   515,622    
Reissuance of treasury stock in business combination 5,584   (705) $ 6,289    
Stock-based compensation 2,281   2,281      
Exercise of stock-based awards, net of shares withheld (in shares)   85,580        
Exercise of stock-based awards, net of shares withheld 315   315      
Unrealized gain (loss) on interest rate caplets 1,907       1,907  
Net income 22,464         22,464
Ending balance (in shares) at Jun. 30, 2022   90,759,331        
Ending balance at Jun. 30, 2022 173,875 $ 9 191,190 $ (42,126) 6,771 18,031
Ending balance (in shares) at Jun. 30, 2022       (3,600,086)    
Beginning balance (in shares) at Dec. 31, 2022   86,674,390        
Beginning balance at Dec. 31, 2022 178,590 $ 9 194,157 $ (81,697) 12,240 53,881
Beginning balance (in shares) at Dec. 31, 2022       (7,829,661)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (476,718)   (476,718)    
Repurchase of common stock (4,206)     $ (4,206)    
Stock-based compensation 1,688   1,688      
Exercise of stock-based awards, net of shares withheld (in shares)   247,153        
Exercise of stock-based awards, net of shares withheld (602)   (602)      
Unrealized gain (loss) on interest rate caplets (2,166)       (2,166)  
Net income 9,182         9,182
Ending balance (in shares) at Mar. 31, 2023   86,444,825        
Ending balance at Mar. 31, 2023 182,486 $ 9 195,243 $ (85,903) 10,074 63,063
Ending balance (in shares) at Mar. 31, 2023       (8,306,379)    
Beginning balance (in shares) at Dec. 31, 2022   86,674,390        
Beginning balance at Dec. 31, 2022 $ 178,590 $ 9 194,157 $ (81,697) 12,240 53,881
Beginning balance (in shares) at Dec. 31, 2022       (7,829,661)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares) (1,363,892)          
Repurchase of common stock $ (12,300)          
Unrealized gain (loss) on interest rate caplets (104)          
Net income 19,165          
Ending balance (in shares) at Jun. 30, 2023   85,605,725        
Ending balance at Jun. 30, 2023 188,748 $ 9 197,690 $ (94,133) 12,136 73,046
Ending balance (in shares) at Jun. 30, 2023       (9,193,553)    
Beginning balance (in shares) at Mar. 31, 2023   86,444,825        
Beginning balance at Mar. 31, 2023 182,486 $ 9 195,243 $ (85,903) 10,074 63,063
Beginning balance (in shares) at Mar. 31, 2023       (8,306,379)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (887,174)   (887,174)    
Repurchase of common stock (8,230)     $ (8,230)    
Stock-based compensation 2,567   2,567      
Exercise of stock-based awards, net of shares withheld (in shares)   48,074        
Exercise of stock-based awards, net of shares withheld (120)   (120)      
Unrealized gain (loss) on interest rate caplets 2,062       2,062  
Net income 9,983         9,983
Ending balance (in shares) at Jun. 30, 2023   85,605,725        
Ending balance at Jun. 30, 2023 $ 188,748 $ 9 $ 197,690 $ (94,133) $ 12,136 $ 73,046
Ending balance (in shares) at Jun. 30, 2023       (9,193,553)